<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cancer risk in the autoimmune rheumatic diseases reported in several meta-analyses</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cancer risk in the autoimmune rheumatic diseases reported in several meta-analyses</h1>
<div class="graphic"><div class="figure"><div class="ttl">Cancer risk in the autoimmune rheumatic diseases reported in several meta-analyses</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1">Disease</td> <td class="subtitle1">Author (year)</td> <td class="subtitle1">Pooled SIR or RR for all cancers</td> <td class="subtitle1">Tumor types with increased risk</td> </tr> <tr> <td>Rheumatoid arthritis</td> <td>Simon (2015)<sup>[1]</sup></td> <td>1.09 (1.06, 1.13)</td> <td>Lymphoma (Hodgkin, non-Hodgkin), lung, melanoma</td> </tr> <tr> <td>Systemic lupus erythematosus</td> <td>Bernatsky (2013)<sup>[2]</sup></td> <td>1.14 (1.05, 1.23)</td> <td>Lymphoma (non-Hodgkin), lung, leukemia, thyroid</td> </tr> <tr> <td>Systemic sclerosis (scleroderma)</td> <td>Onishi (2013)<sup>[3]</sup></td> <td>1.41 (1.18, 1.68)</td> <td>Lung, liver, hematologic, bladder</td> </tr> <tr> <td> <p>Myositis</p> <p><span class="indent1"><span style="font-size: 10pt; font-family: 'Verdana',sans-serif; line-height: 107%; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">–</span> Polymyositis</span> </p> <p><span class="indent1"></span> </p> <p><span class="indent1"><span style="font-size: 10pt; font-family: 'Verdana',sans-serif; line-height: 107%; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">–</span> Dermatomyositis</span> </p> </td> <td>Yang (2015)<sup>[4]</sup></td> <td> <p> </p> <p><span style="font-size: 10pt; font-family: 'Verdana',sans-serif; line-height: 107%; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">–</span> 1.62 (1.19, 2.04) </p> <p> </p> <p><span style="font-size: 10pt; font-family: 'Verdana',sans-serif; line-height: 107%; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">– </span>5 .50 (4.31, 6.70) </p> </td> <td> <p> </p> <p><span style="font-size: 10pt; font-family: 'Verdana',sans-serif; line-height: 107%; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">–</span> Lung, kidney, breast, lymphoma, bladder, endometrial, cervical, thyroid, brain </p> <p> </p> <p><span style="font-size: 10pt; font-family: 'Verdana',sans-serif; line-height: 107%; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">–</span> Ovary, breast, lung, colorectal, cervical, bladder, nasopharyngeal, esophagus, pancreas, kidney </p> </td> </tr> <tr> <td>Sjögren's syndrome</td> <td>Liang (2014)<sup>[5]</sup></td> <td>1.53 (1.17, 1.88)</td> <td>Non-Hodgkin lymphoma, thyroid</td> </tr> <tr> <td>ANCA-associated vasculitis</td> <td>Shang (2015)<sup>[6]</sup></td> <td>1.74 (1.37, 2.21)</td> <td>Non-melanoma skin, leukemia, bladder, lymphoma, liver, lung</td> </tr> </tbody></table></div><div class="graphic_footnotes">SIR: standardized incidence ratio; RR: risk ratio; ANCA: antineutrophil cytoplasmic antibody.</div><div class="graphic_reference">References: 

<ol>
<li>Simon TA, Thompson A, Gandhi KK, et al. Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis. Arthritis Res Ther 2015; 17:212.</li>
<li>Bernatsky S, Ramsey-Goldman R, Labrecque J, et al. Cancer risk in systemic lupus: An updated international multi-centre cohort study. J Autoimmun 2013; 42:130.</li>
<li>Onishi A, Sugiyama D, Kumagai S, Morinobu A. Cancer incidence in systemic sclerosis: Meta-analysis of population-based cohort studies. Arthritis Rheum 2013; 65:1913.</li>
<li>Yang Z, Lin F, Qin B, et al. Polymyositis/dermatomyositis and malignancy risk: A metaanalysis study. J Rheumatol 2015; 42:282.</li>
<li>Liang Y, Yang Z, Qin B, Zhong R. Primary Sjogren's syndrome and malignancy risk: A systematic review and meta-analysis. Ann Rheum Dis 2014; 73:1151.</li>
<li>Shang W, Ning Y, Xu X, et al. Incidence of cancer in ANCA-associated vasculitis: A meta-analysis of observational studies. PLoS One 2015; 10:e0126016.</li></ol>Reproduced from: Egiziano G, Bernatsky S, Shah AA. Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link. Best Pract Res Clin Rheumatol 2016; 30:53. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 115875 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
